Licensing Out

Our goal is to provide patients with high-quality product in the shortest time possible. Out-licensing reduces our time-to-market, ensuring that the therapies of the future reach those who need them most.

The following out-licensing opportunities are currently available:

Product: Nasodren®


  • Acute or chronic recurrent inflammation of the para nasal sinuses (rhinosinusitis): catarrhal or purulent maxillary rhinosinusitis, frontitis, ethmoiditis, sphenoiditis, or combined rhinosinusitis.
  • Acute purulent rhinosinusitis, accompanied by generalized infection or orbital complications.
  • In case of orbital complications or generalized infection, NASODREN® should be administered in combination with antibiotics.
  • Acute exudative or purulent otitis media, chronic exudative, acute secretory otitis media or purulent otitis media. In case of fever, Nasodren® should be administered in combination with antibiotics.
  • In postoperative care, after nasal or nasosinusal surgery.

For more details please contact us:

e-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.